Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
blueprint medicines
boston blog main
boston top stories
clinical trials
eli lilly
fda
2
×
life sciences
national blog main
san francisco blog main
avapritinib
black diamond therapeutics
bladder cancer
boston
cancer
cancer drugs
cstone pharmaceuticals
deals
deciphera pharmaceuticals
endometral cancer
europe blog main
european medicines agency
european society for medical oncology
fisogatinib
flatiron health
genentech
glioblastoma
hepatocellular carcinoma
investing
jeff albers
loxo oncology
medullary thyroid cancer
mirati therapeutics
national top stories
new enterprise associates
non-small cell lung cancer
pralsetinib
roche
san francisco top stories
selpercatinib
What
cancer
2
×
drug
medicines
2
×
approval
biotech
black
blueprint
candidate
clinic
companies
currently
diamond
eluded
fda
hopes
ipo
lead
leading
lines
marketing
molecular
muscle
nears
new
pact
phase
ready
regulatory
research
ret
review
roche
targets
team
therapeutics
wins
Language
unset
Current search:
fda
×
biotech
×
cancer
×
medicines
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
